Schrodinger's stock has performed well this year due to AI hype and strength in its drug discovery business. While the company appears attractively valued from a long-term perspective, the tight ...

Schrodinger reported robust software and drug discovery revenue in the second quarter. Lilly's planned multi-billion-dollar acquisition of Morphic also provides another validation point for ...

Devised in 1935 by the Austrian physicist Erwin Schrödinger, this thought experiment was designed to shine a spotlight on the difficulty with interpreting quantum theory. Quantum theory is very ...